FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/04/109234 [Registered on: 23/04/2026] Trial Registered Prospectively
Last Modified On: 22/04/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Dentistry 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Can Telephone Support Help People Who Use Chewing Tobacco to Quit? Evidence from Odisha 
Scientific Title of Study   Effectiveness of National Tobacco Quitline Services (NTQLS) in cessation among smokeless tobacco (SLT) users: A randomised controlled trial in Tertiary care Hospital, Odisha 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr SATYAPRABHA ROUT 
Designation  MDS 1ST YEAR 
Affiliation  SCB DENTAL COLLEGE AND HOSPITAL,CUTTACK,ODISHA, Odisha 
Address  PUBLIC HEALTH DENTISTRY,SCB DENTAL COLLEGE AND HOSPITAL,MANGALABAG, CUTTACK, ODISHA, 753007,INDIA

Cuttack
ORISSA
753007
India 
Phone  8144644868  
Fax    
Email  satyaprabha2016@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr UTKAL KESHARI MOHANTY 
Designation  ASSOCIATE PROFESSOR 
Affiliation  SCB DENTAL COLLEGE AND HOSPITAL,CUTTACK,ODISHA, Odisha 
Address  DEPT OF PUBLIC HEALTH DENTISTRY, SCB DENTAL COLLEGE AND HOSPITAL, MANGALABAG, CUTTACK, ODISHA, 753007, INDIA

Cuttack
ORISSA
753007
India 
Phone  9437953285  
Fax    
Email  utkalcommunity@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr HEMAMALINI RATH 
Designation  HEAD OF THE DEPARTMENT AND PROFESSOR 
Affiliation  SCB DENTAL COLLEGE AND HOSPITAL,CUTTACK,ODISHA, Odisha 
Address  DEPT OF PUBLIC HEALTH DENTISTRY, SCB DENTAL COLLEGE AND HOSPITAL, MANGALABAG, CUTTACK,ODISHA,753007, INDIA

Cuttack
ORISSA
753007
India 
Phone  9437225245  
Fax    
Email  hema_hr@rediffmail.com  
 
Source of Monetary or Material Support  
NIL 
 
Primary Sponsor  
Name  Dr SATYAPRABHA ROUT 
Address  SCB DENTAL COLLEGE AND HOSPITAL, MANGALABAG,CUTTACK,ODISHA,753007 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr SATYAPRABHA ROUT  SCB DENTAL COLLEGE AND HOSPITAL  TOBACCO CESSATION CENTER ,SCB DENTAL COLLEGE AND HOSPITAL MANGALABAG, CUTTACK, ODISHA, 753007, INDIA
Cuttack
ORISSA 
08144644868

satyaprabha2016@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE SCB DENTAL COLLEGE AND HOSPITAL CUTTACK,ODISHA  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  SMOKELESS TOBACCO USERS 
Patients  (1) ICD-10 Condition: K088||Other specified disorders of teethand supporting structures,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  BEHAVIOURAL COUNSELLING  At baseline, participants will receive behavioural counselling delivered by principal investigator and will be followed up at 4, 8, 12, and 24 weeks, with additional self help information brochures to reinforce cessation efforts. 
Intervention  BEHAVIOURAL COUNSELLING  Participants will be given a brief advice on harmful effect of tobacco and enrolled in the National Tobacco Quitline Services (NTQLS) through the designated toll-free number 1800-11-2356 with supplementary information brochure. Follow-up assessments will be conducted at 4, 8, 12, and 24 weeks to evaluate their utilization of the service. During each follow-up, participants will be asked to report whether they received proactive and reactive calls from the NTQLS. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1.Patients of all age groups referred to TCC of SCB Dental College and Hospital, Cuttack will be included in the study.
2.Individuals who are current users of smokeless tobacco products (such as gutkha, khaini, pan masala with tobacco, snuff, or other forms).
3.Individuals who are willing to quit smokeless tobacco.
4.Individuals willing to participate in the cessation intervention.
 
 
ExclusionCriteria 
Details  1.Individuals who consume or use smoked tobacco products only (cigarettes/bidis) without smokeless tobacco use.
2.Individuals who are currently enrolled in any other tobacco cessation program or clinical trial.
3.Individuals receiving pharmacotherapy for tobacco cessation (nicotine replacement therapy, bupropion, varenicline, or other medications) at the time of recruitment.
4.Individuals with serious medical illnesses or unstable systemic conditions that may interfere with participation or follow-up (e.g., severe cardiac disease, uncontrolled diabetes, or malignancy).
5.Individuals with psychiatric disorders or cognitive impairment that limit their ability to provide reliable information or informed consent.
6.Individuals who are not willing to provide informed consent or unable to comply with the study protocol and scheduled follow-up visits.
7.Participants who plan to relocate or are unlikely to be available for the 24-week follow-up period
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Point prevalence abstinence from smokeless tobacco use at 4,8,12,24 weeks  4,8,12,24 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
1.Prolonged abstinence (continuous cessation) over a period of 24 weeks
2.Number and frequency of quit attempts
3.Proportion of participants with relapse
4.Salivary cotinine level assessment at the end of 24 weeks.
 
6 MONTHS 
 
Target Sample Size   Total Sample Size="264"
Sample Size from India="264" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/07/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study evaluates the effectiveness of National Tobacco Quitline Services (NTQLS) in helping smokeless tobacco users quit. It is a randomized controlled trial conducted among 264 participants at a tertiary care hospital in Odisha, comparing behavioural counselling alone with counselling plus quitline support. Participants will be followed for 24 weeks to assess abstinence, quit attempts, and relapse. The findings aim to determine whether NTQLS improves cessation outcomes and can serve as an effective, accessible public health strategy for tobacco control.


 
Close